Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation.

[1]  C. Farrell,et al.  Task Force , 2021, Across the Generations.

[2]  L. Rabeneck,et al.  Organized Lung Cancer Screening Pilot: Informing a Province-wide Program in Ontario, Canada. , 2020, The Annals of thoracic surgery.

[3]  A. Frille,et al.  Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial , 2020, Breathe.

[4]  P. Brennan,et al.  Assessment of Biomarker Testing for Lung Cancer Screening Eligibility , 2020, JAMA network open.

[5]  Harry J de Koning,et al.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.

[6]  M. Mascalchi,et al.  Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factors. , 2019, Lung cancer.

[7]  Sam M. Janes,et al.  PL02.02 Lung Cancer Screenee Selection by USPSTF Versus PLCOm2012 Criteria – Interim ILST Findings , 2019, Journal of Thoracic Oncology.

[8]  J. Eberth,et al.  Lung Cancer Screening Utilization: A Behavioral Risk Factor Surveillance System Analysis. , 2019, American journal of preventive medicine.

[9]  Ya-Hui Chang,et al.  Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis , 2019, BMC Pulmonary Medicine.

[10]  Eric A. Miller,et al.  Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial National Lung Screening Trial Writing Team 1. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  H. Kauczor,et al.  Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trial , 2019, International journal of cancer.

[12]  G. Corrado,et al.  End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography , 2019, Nature Medicine.

[13]  P. Massion,et al.  Low Provider Knowledge Is Associated With Less Evidence-Based Lung Cancer Screening. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[14]  A. B. Borondy Kitts,et al.  The Patient Perspective on Lung Cancer Screening and Health Disparities. , 2019, Journal of the American College of Radiology : JACR.

[15]  G. Corrao,et al.  Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Wei-min Li,et al.  Implementation planning for lung cancer screening in China , 2019, Precision clinical medicine.

[17]  Summer S. Han,et al.  Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results , 2019, JAMA network open.

[18]  J. Goodwin,et al.  Use of Lung Cancer Screening With Low-Dose Computed Tomography in the Medicare Population , 2019, Mayo Clinic proceedings. Innovations, quality & outcomes.

[19]  Hyae-Young Kim,et al.  Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program , 2019, Cancer research and treatment : official journal of Korean Cancer Association.

[20]  P. Pandharipande,et al.  Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective. , 2019, Radiology.

[21]  R. Booton,et al.  The cost-effectiveness of the Manchester 'lung health checks', a community-based lung cancer low-dose CT screening pilot. , 2018, Lung cancer.

[22]  H. Chalian,et al.  Demographic, Social, and Behavioral Determinants of Lung Cancer Perceived Risk and Worries in a National Sample of American Adults; Does Lung Cancer Risk Matter? , 2018, Medicina.

[23]  R. Booton,et al.  Second round results from the Manchester ‘Lung Health Check’ community-based targeted lung cancer screening pilot , 2018, Thorax.

[24]  S. Hiom,et al.  Lung cancer screening - gaining consensus on next steps - proceedings of a closed workshop in the UK. , 2018, Lung cancer.

[25]  C. Thomson,et al.  American Thoracic Society/American Lung Association Lung Cancer Screening Implementation Guide. , 2018, American journal of respiratory and critical care medicine.

[26]  Chyke A Doubeni,et al.  Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: US Preventive Services Task Force Final Recommendation Statement , 2018, JAMA.

[27]  M. Oudkerk,et al.  PL02.05 Effects of Volume CT Lung Cancer Screening: Mortality Results of the NELSON Randomised-Controlled Population Based Trial , 2018, Journal of Thoracic Oncology.

[28]  A. Flahault,et al.  Participation in lung cancer screening programs: are there gender and social differences? A systematic review , 2018, Public Health Reviews.

[29]  J. Ostroff,et al.  Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum. , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[30]  H. Luft,et al.  New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low , 2018, BMC Health Services Research.

[31]  G. Kloecker,et al.  Lung cancer screening rates: Data from the lung cancer screening registry. , 2018 .

[32]  J. Seely,et al.  Screening for breast cancer in 2018-what should we be doing today? , 2018, Current oncology.

[33]  P. Mazzone,et al.  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report , 2018, Chest.

[34]  Brady J. McKee,et al.  NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[35]  K. Hveem,et al.  A Validated Clinical Risk Prediction Model for Lung Cancer in Smokers of All Ages and Exposure Types: A HUNT Study , 2018, EBioMedicine.

[36]  Witold Rzyman,et al.  European position statement on lung cancer screening. , 2017, The Lancet. Oncology.

[37]  S. Lam,et al.  Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. , 2017, The Lancet. Oncology.

[38]  Ahmedin Jemal,et al.  Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015 , 2017, JAMA oncology.

[39]  C. la Vecchia,et al.  Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials , 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[40]  M. Oudkerk,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[41]  Eugenio Paci,et al.  Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial , 2017, Thorax.

[42]  P. V. Van Schil,et al.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[43]  A. Bankier,et al.  Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. , 2017, Radiology.

[44]  P. Brennan,et al.  Lung Cancer Risk Prediction Model Incorporating Lung Function: Development and Validation in the UK Biobank Prospective Cohort Study. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  Emily B. Peterson,et al.  Impact of provider-patient communication on cancer screening adherence: A systematic review. , 2016, Preventive medicine.

[46]  Kathleen B. Cartmell,et al.  Knowledge of, attitudes toward, and use of low‐dose computed tomography for lung cancer screening among family physicians , 2016, Cancer.

[47]  H. Ashraf,et al.  Smoking cessation and lung cancer screening. , 2016, Annals of translational medicine.

[48]  Brady J. McKee,et al.  Smoking cessation results in a clinical lung cancer screening program. , 2016, Journal of thoracic disease.

[49]  P. V. van Ooijen,et al.  Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval , 2016, Thorax.

[50]  Stephanie A Kovalchik,et al.  Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. , 2016, JAMA.

[51]  John K Field,et al.  The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. , 2016, Health technology assessment.

[52]  Asger Dirksen,et al.  Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. , 2016, American journal of respiratory and critical care medicine.

[53]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[54]  D. Hansell,et al.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening , 2015, Thorax.

[55]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2016 , 2015, MMWR. Morbidity and mortality weekly report.

[56]  D. Midthun,et al.  An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. , 2015, American journal of respiratory and critical care medicine.

[57]  Brady J. McKee,et al.  Surgical Outcomes in a Large, Clinical, Low-Dose Computed Tomographic Lung Cancer Screening Program. , 2015, The Annals of thoracic surgery.

[58]  J. Weissfeld,et al.  A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor. , 2015, Lung cancer.

[59]  M. Prokop,et al.  British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE , 2015, Thorax.

[60]  M. Scorsetti,et al.  Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. , 2015, American journal of respiratory and critical care medicine.

[61]  H. Kauczor,et al.  ESR/ERS white paper on lung cancer screening , 2015, European Respiratory Journal.

[62]  E. Kazerooni,et al.  Performance of Lung-RADS in the National Lung Screening Trial , 2015, Annals of Internal Medicine.

[63]  Brady J. McKee,et al.  Low-dose Computed Tomography Screening for Lung Cancer in a Clinical Setting: Essential Elements of a Screening Program , 2015, Journal of thoracic imaging.

[64]  Brady J. McKee,et al.  Performance of ACR Lung-RADS in a clinical CT lung screening program. , 2015, Journal of the American College of Radiology : JACR.

[65]  Karl Claxton,et al.  Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. , 2015, Health technology assessment.

[66]  Arash Naeim,et al.  Cost-effectiveness of CT screening in the National Lung Screening Trial. , 2014, The New England journal of medicine.

[67]  Heidi Roberts,et al.  Resource Utilization and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography in Canada , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[68]  David F Yankelevitz,et al.  CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases. , 2014, Radiology.

[69]  Heidi Roberts,et al.  Screening High-Risk Populations for Lung Cancer: Guideline Recommendations , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[70]  Yiding Jiang,et al.  A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions , 2013, PloS one.

[71]  M. Mascalchi,et al.  Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[72]  Timothy R Church,et al.  Selection criteria for lung-cancer screening. , 2013, The New England journal of medicine.

[73]  E. Quoix,et al.  From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF) , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[74]  S. Duffy,et al.  Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer , 2012, Annals of Internal Medicine.

[75]  Heber MacMahon,et al.  The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. , 2012, The Journal of thoracic and cardiovascular surgery.

[76]  C. Hoggart,et al.  A risk model for lung cancer incidence. , 2012, Cancer prevention research.

[77]  Ugo Pastorino,et al.  Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[78]  Yiding Jiang,et al.  An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. , 2012, Health affairs.

[79]  Denise R. Aberle,et al.  Baseline Characteristics of Participants in the Randomized National Lung Screening Trial , 2010, Journal of the National Cancer Institute.

[80]  S. Duffy,et al.  Comparison of discriminatory power and accuracy of three lung cancer risk models , 2010, British Journal of Cancer.

[81]  S. Duffy,et al.  Abstract A127: Comparison of discriminatory power and accuracy of three lung cancer risk models , 2010 .

[82]  P. V. van Ooijen,et al.  Management of lung nodules detected by volume CT scanning. , 2009, The New England journal of medicine.

[83]  A. Dirksen,et al.  The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[84]  U. P. S. T. Force.  Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. , 2009 .

[85]  M. Spitz,et al.  Development and Validation of a Lung Cancer Risk Prediction Model for African-Americans , 2008, Cancer Prevention Research.

[86]  Federico Cappuzzo,et al.  Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. , 2008, Lung cancer.

[87]  S. Duffy,et al.  The LLP risk model: an individual risk prediction model for lung cancer , 2007, British Journal of Cancer.

[88]  Matthew B Schabath,et al.  A risk model for prediction of lung cancer. , 2007, Journal of the National Cancer Institute.

[89]  O. Miettinen,et al.  Survival of patients with stage I lung cancer detected on CT screening. , 2006, The New England journal of medicine.

[90]  Kathleen A Cronin,et al.  Validation of a model of lung cancer risk prediction among smokers. , 2006, Journal of the National Cancer Institute.

[91]  C. Begg,et al.  Variations in lung cancer risk among smokers. , 2003, Journal of the National Cancer Institute.

[92]  A. Gelfand,et al.  Predicting the cumulative risk of false-positive mammograms. , 2000, Journal of the National Cancer Institute.

[93]  R. Doll,et al.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.

[94]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[95]  N. Tanner,et al.  Shared Decision-making and Lung Cancer Screening: Let's Get the Conversation Started. , 2019, Chest.

[96]  R. Nelson,et al.  The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low‐Dose Computed Tomography , 2018, Clinical lung cancer.

[97]  Brian A. King,et al.  Current cigarette smoking among adults - United States, 2005-2014. , 2015, MMWR. Morbidity and mortality weekly report.

[98]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[99]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[100]  L. Tanoue.  Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. , 2009, Annals of internal medicine.

[101]  G. Colditz,et al.  Online Continuing Education Activity Article Title: American Cancer Society Lung Cancer Screening Guidelines Continuing Medical Education Accreditation and Designation Statement: Continuing Nursing Education Accreditation and Designation Statement: Educational Objectives: Activity Disclosures Acs Co , 2022 .